MYCN AMPLIFICATION PREDICTED A WORSE PROGNOSIS IN PATIENTS WITH LOWER-GRADE IDH-MUTANT GLIOMAS AND WAS RELATED TO THE EPITHELIOID HISTOLOGICAL FEATURES

被引:0
|
作者
Xi, S. [1 ]
Xie, X. [1 ]
Qin, Y. [1 ]
Lu, J. [1 ]
机构
[1] Sun yat sen Univ Canc Ctr, Guangzhou, Peoples R China
关键词
D O I
10.1093/neuonc/noae144.346
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P18.30.B
引用
收藏
页码:V104 / V104
页数:1
相关论文
共 50 条
  • [21] Clinical characteristics and radiological features of glioblastoma, IDH-wildtype, grade 4 with histologically lower-grade gliomas
    Motomura, Kazuya
    Kibe, Yuji
    Ohka, Fumiharu
    Aoki, Kosuke
    Yamaguchi, Junya
    Saito, Ryuta
    BRAIN TUMOR PATHOLOGY, 2023, 40 (02) : 48 - 55
  • [22] An Immune-Related Prognostic Signature for Predicting Clinical Outcomes and Immune Landscape in IDH- Mutant Lower-Grade Gliomas
    Xiao, Gang
    Gao, Xuan
    Li, Lifeng
    Liu, Chao
    Liu, Zhiyuan
    Peng, Haiqin
    Xia, Xuefeng
    Yi, Xin
    Zhou, Rongrong
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [23] Clinical characteristics and radiological features of glioblastoma, IDH-wildtype, grade 4 with histologically lower-grade gliomas
    Kazuya Motomura
    Yuji Kibe
    Fumiharu Ohka
    Kosuke Aoki
    Junya Yamaguchi
    Ryuta Saito
    Brain Tumor Pathology, 2023, 40 : 48 - 55
  • [24] UPFRONT VERSUS DEFERRED TREATMENT IN LOWER GRADE IDH-MUTANT GLIOMAS: A SINGLE-CENTER RETROSPECTIVE ANALYSIS
    Patel, Anuj
    Whitfield, Benjamin
    Ballester, Leomar
    Puduvalli, Vinay
    Kamiya-Matsuoka, Carlos
    NEURO-ONCOLOGY, 2023, 25
  • [25] Volumetric analysis of IDH-mutant lower-grade glioma: a natural history study of tumor growth rates before and after treatment
    Huang, Raymond Y.
    Young, Robert J.
    Ellingson, Benjamin M.
    Veeraraghavan, Harini
    Wang, Wei
    Tixier, Florent
    Um, Hyemin
    Nawaz, Rasheed
    Luks, Tracy
    Kim, John
    Gerstner, Elizabeth R.
    Schiff, David
    Peters, Katherine B.
    Mellinghoff, Ingo K.
    Chang, Susan M.
    Cloughesy, Timothy F.
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2020, 22 (12) : 1822 - 1830
  • [26] A gene signature predicting prognosis of patients with lower-grade gliomas receiving temozolomide therapy
    Wan, Yanzhi
    Li, Guangqi
    Deng, Junyue
    Zhu, Hong
    Ma, Xuelei
    DISCOVER ONCOLOGY, 2023, 14 (01)
  • [27] A gene signature predicting prognosis of patients with lower-grade gliomas receiving temozolomide therapy
    Yanzhi Wan
    Guangqi Li
    Junyue Deng
    Hong Zhu
    Xuelei Ma
    Discover Oncology, 14
  • [28] NEOANTIGEN-SPECIFIC T CELLS CAN INFILTRATE IDH-MUTANT LOWER GRADE GLIOMAS AND PERSIST IN THE PERIPHERAL BLOOD
    Zhang, Michael
    Wang, Cliff
    Pan, Zheng
    Yuen, Benjamin
    Peng, Songming
    Kwok, Darwin
    Nejo, Takahide
    Martin, Michael
    Hong, Chibo
    Hilz, Stephanie
    Phillips, Joanna
    Shai, Anny
    Oberheim-Bush, Nancy Ann
    Hervey-Jumper, Shawn
    McDermott, Michael
    Mandl, Stefanie
    Okada, Hideho
    Costello, Joseph
    NEURO-ONCOLOGY, 2021, 23 : 99 - 100
  • [29] IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis
    Satoshi Nakasu
    Shoichi Deguchi
    Yoko Nakasu
    Brain Tumor Pathology, 2023, 40 : 143 - 157
  • [30] The prognostic power of [11C]methionine PET in IDH-wildtype diffuse gliomas with lower-grade histological features: venturing beyond WHO classification
    Gaia Ninatti
    Cristiano Pini
    Beatrice Claudia Bono
    Fabrizia Gelardi
    Lidija Antunovic
    Bethania Fernandes
    Martina Sollini
    Claudio Landoni
    Arturo Chiti
    Federico Pessina
    Journal of Neuro-Oncology, 2023, 164 (2) : 473 - 481